NAMS - Financial Reports List - NewAmsterdam Pharma Company N.V. - IntrinsicAlpha

NewAmsterdam Pharma Company N.V. NAMS

Healthcare - Biotechnology - NASDAQ - NL

$ 18.5076

-4.34 %

$ 2.08 B

Market Cap

-10.06

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	129.38%	100.00%	100.00%
Quarterly Report	Q4	8-K	2024-12-31	700.98%	-116.69%	2.41%
Annual Report	FY	10-K	2024-12-31	257.00%	-36.54%	-6.37%
Quarterly Report	Q3	8-K	2024-09-30	1450.69%	63.88%	49.21%
Quarterly Report	Q2	8-K	2024-06-30	35.21%	-3.77%	-26.07%
Quarterly Report	Q1	8-K	2024-03-31	-83.68%	-124.32%	-39.94%
Quarterly Report	Q4	8-K	2023-12-31	15.18%	-5.17%	-45.57%
Annual Report	FY	10-K	2023-12-31	-86.69%	-737.06%	-4889.08%
Quarterly Report	Q3	8-K	2023-09-30	-66.58%	-18.71%	-67.46%
Quarterly Report	Q2	8-K	2023-06-30	-96.63%	-128.74%	-145.21%

1